We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ImprimisRx Gets Form 483 for Unsanitary Conditions, Drug Quality Issues
ImprimisRx Gets Form 483 for Unsanitary Conditions, Drug Quality Issues
The FDA issued a nine-observation Form 483 to ImprimisRx’s Ledgewood, N.J., facility for unsanitary conditions and other deficiencies observed during a July 11 to Aug. 5 inspection.
